The International ADHD in Substance Use Disorders Prevalence (IASP) study: Background, methods and study population

International Journal of Methods in Psychiatric Research

Volumn 22, Issue 3, 2013, Pages 232-244

  Van de Glind, Geurt ^a,c   Van Emmerik van Oortmerssen, Katelijne ^b,c   Carpentier, Pieter Jan ^d   Levin, Frances R ^e   Koeter, Maarten W J ^c   Barta, Csaba ^f   Kaye, Sharlene ^g   Skutle, Arvid ^h   Franck, Johan ⁱ   Konstenius, Maija ⁱ   Bu, Eli Torild ^h   Moggi, Franz ^j   Dom, Geert ^k   Demetrovics, Zolt ^f   Fatséas, Mélina ^l   Schillinger, Arild ^m   Kapitány Fövény, Máté ^f   Verspreet, Sofie ^k   Seitz, Andrea ⁿ   Johnson, Brian ^o   Faraone, Stephen V ^o   Ramos Quiroga, J Antoni ^p   Allsop, Steve ^q   Carruthers, Susan ^q   Schoevers, Robert A ^r   Løvaas, Eva Karin ^s   Lossius, Kari ^s   van Wamel, Anneke ^s   Bosma, Geert ^s   Hay, David ^s   Wallhed, Sara ^s   Auriacombe, Marc ^s   Malivert, Marion ^s   Debrabant, Romain ^s   Dahl, Therese ^s   Casas, Miguel ^s   Daigre, Constanza ^s   van der Gaag, Rutger Jan ^s   Beniwal, Atul ^s   Degenhardt, Louisa ^s   Cassar, Joanne ^s   Young, Jesse ^s   Möller, Merete ^s   van den Brink, Wim ^c   more..

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^b Arkin   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d Reinier Van Arkel Groep   (Netherlands)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^f EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h Bergen Clinics Foundation   (Norway)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j UNIVERSITY OF FRIBOURG   (Switzerland)

^k PC Alexian Brothers   (Belgium)

^l UNIVERSITÉ DE BORDEAUX   (France)

^m Østfold Hospital Trust   (Norway)

ⁿ UNIVERSITY OF BERN   (Switzerland)

^o SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^p HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^q CURTIN UNIVERSITY   (Australia)

^r UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^s NONE

more..

Author keywords

ADHD; Attention deficit hyperactivity disorder; Prevalence; Substance use disorders

Indexed keywords

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CLINICAL TRIAL; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PROTECTION; PSYCHOMETRY; QUESTIONNAIRE; REPRODUCIBILITY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; VALIDATION STUDY; YOUNG ADULT;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROTECTIVE FACTORS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84884702796     PISSN: 10498931     EISSN: 15570657     Source Type: Journal    
DOI: 10.1002/mpr.1397     Document Type: Article

References (53)

1. Arcos-Burgos M., Jain M., Acosta M.T., Shively S., Stanescu H., Wallis D., Domené S., Vélez J.I., Karkera J.D., Balog J., Berg K., Kleta R., Gahl W.A., Roessler E., Long R., Lie J., Pineda D., Londoño A.C., Palacio J.D., Arbelaez A., Lopera F., Elia J., Hakonarson H., Johansson S., Knappskog P.M., Haavik J., Ribases M., Cormand B., Bayes M., Casas M., Ramos-Quiroga J.A., Hervas A., Maher B.S., Faraone SV., Seitz C., Freitag C. M., Palmason H., Meyer J., Romanos M., Walitza S., Hemminger U., Warnke A., Romanos J., Renner T., Jacob C., Lesch K.P., Swanson J., Vortmeyer A., Bailey-Wilson J.E., Castellanos F.X., Muenke M.. (2010) A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Molecular Psychiatry, 15, 1053-1066, DOI: 10.1038/mp.2010.6.
2. Adler L.A., Guida F., Irons S., Rotrosen J., O'Donnell K. (2009) Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility. Postgraduate Medicine, 121(5), 7-10.
3. Arias A.J., Gelernter J., Chan G., Weiss R.D., Brady K.T., Farrer L., Kranzler H.R. (2008) Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addictive Behaviors, 33, 1199-207.
4. Batstra L., Frances A. (2012) Holding the line against diagnostic inflation in psychiatry. Psychotherapy and Psychosomatics, 81(1), 5-1081.
5. Barkley R.A., Murphy K.R., Fischer M. (2008) ADHD in Adults: What the Science Says, New York: The Guilford Press.
6. Biederman J., Wilens T., Mick E., Milberger S., Spencer T., Faraone S. (1995) Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder: effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry, 152, 1652-1658.
7. Biederman J., Wilens T., Mick E., Faraone S., Spencer T. (1998) Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biological Psychiatry, 44, 269-273.
8. Chiasson J.P., Stavro K., Rizkallah E., Lapierre L., Dussault M., Legault L., Potvin S. (2011) Questioning the specificity of ASRS-v1.1 to accurately detect ADHD in substance abusing populations. Journal of Attention Disorders, 16(8), 661-663. DOI: 1087054711425768.
9. Charach A., Yeung E., Climans T., Lillie E. (2011) Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. Journal of the American Academy of Child & Adolescent Psychiatry, 50(1), 9-21.
10. Clure C., Brady K.T., Saladin M.E., Johnson D., Waid R., Rittenbury M. (1999) Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. American Journal of Drug and Alcohol Abuse, 25, 441-448.
11. Conners Adult ADHD Diagnostic Interview for Q1 DSM-IV. 2013. Rev Psiquiatr Salud Ment (Barc.).
12. Daigre Blanco C., Ramos-Quiroga J.A., Valero S., Bosch R., Roncero C., Gonzalvo B., Nogueira M. (2009) Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist in patients with substance use disorders. Actas Españolas de Psiquiatría, 37, 299-305.
13. DuPaul G.J., Schaughency E.A., Weyandt L.L., Tripp G., Kiesner J., Ota K., Stanish H. (2001) Self-report of ADHD symptoms in university students: cross-gender and cross-national prevalence. Journal of Learning Disabilities, 34(4), 370-379.
14. Epstein J.E., Johnson D.E., Conners C.K. (2001) Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID). Technical Manual, Toronto, MHS.
15. Epstein J.N., Kollins S.H. (2006) Psychometric properties of an adult ADHD diagnostic interview. Journal of Attention Disorders, 9(3), 504-514
16. European Medicines Agency (2002). http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf.
17. Fayyad J., Graaf R. de, Kessler R., Alonso J., Angermeyer M., Demyttenaere K., De Girolamo G., Haro J.M., Karam E.G., Lara C., Lepine J.P., Ormel J., Posada-Villa J., Zaslavsky A.M., Jin R. (2007) Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. British Journal of Psychiatry, 190, 402-409.
18. Faraone S.V., Sergeant J., Gillberg C., Biederman J. (2003) The worldwide prevalence of ADHD: is it an American condition? World Psychiatry, 2(2), 104-113.
19. Faraone S., Biederman J., Mick E. (2006) The age dependent decline of attention-deficit/hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine, 36, 159-165.
20. Fatseas M., Debrabant R., Auriacombe M. (2012) The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders. Current Opinion in Psychiatry, 25(3), 219-225.
21. Frances A.J., Widiger T. (2012) Psychiatric diagnosis: lessons from the DSM-IV past and cautions for the DSM-5 future. Annual Review of Clinical Psychology, 8, 109-130.
22. ICASA Foundation Website (2011) http://www.adhdandsubstanceabuse.org/) [20 August 2012].
23. Ilomaki R., Sodervall J., Ilomaki E., Hakko H., Rasanen P. (2008) Drug-dependent boys are more depressed compared to girls: a comorbidity study of substance dependence and mental disorders. European Addiction Research, 14, 161-168.
24. Johann M., Bobbe G., Putzhammer A., Wodarz N. (2003) Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phe-notype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5 hydroxytryptamine-2c receptor). Alcoholism, Clinical and Experimental Research, 27, 1527-1534.
25. Kessler R.C., Adler L., Ames M., Demler O., Faraone S., Hiripi E., Howes M.J., Jin R., Secnik K., Spencer T., Ustun T.B., Walters E.E. (2005) The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychological Medicine, 35(2), 245-256.
26. Kessler R.C., Adler L.A., Gruber M.J., Sarawate C.A., Spencer T., Van Brunt D.L. (2007). Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. International Journal of Methods in Psychiatric Rsearch, 16(2), 52-65.
27. Kiesling R., Rohde L.A. (2012) ADHD in Children and Adults: Diagnosis and Prognosis. In Stanford C., Tannock R. (eds) Behavioral Neuroscience of Attention Deficient Hyperactivity Disorder and Its Treatment. Current Topics in Behavioral Neurosciences 9, pp 1-16, New York: Springer.
28. King V.L., Brooner R.K., Kidorf M.S., Stoller K.B., Mirsky A.F. (1999) Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. Journal of Nervous and Mental Disease, 187, 487-495.
29. Lecrubier Y., Sheehan D.V., Weiller E., Amorim P., Bonora I., Sheehan K.H. (1997) The MINI International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry, 12, 224-231.
30. Lee S.S., Humphreys K.L., Flory K., Liu R., Glass K. (2010) Prospective association of childhood attention-deficit/hyperactive disorder (ADHD) and substance abuse/dependence: a meta-analytic review. Clinical Psychology Review, 31, 328-341.
31. Levin F.R., Evans S.M., Kleber H.D. (1998) Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence, 52, 15-25.
32. Massoubre C., Bonnefond H., Grosselin A., Nelva A., Pellet J., Lang F. (2009) Preliminary comparative study of the personality disorder evaluation DIP instrument with the semi-structured SCID-II interview]. Encephale, 35(6), 544-553.
33. Matza L.S., Van Brunt D.L., Cates C., Murray L.T. (2011) Test-retest reliability of two patient-report measures for use in adults with ADHD. Journal of Attention Disorders, 15(7), 557-563.
34. McAweeney M., Rogers N.L., Huddleston C., Moore D., Gentile J.P. (2010) Symptom prevalence of ADHD in a community residential substance abuse treatment program. Journal of Attention Disorders, 13(6), 601-608.
35. Medori R., Ramos-Quiroga J.A., Casas M., Kooij J.J., Niemelä A., Trott G.E., Buitelaar J.K. (2008) A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biological Psychiatry, 63, 981-989, DOI: 10.1016.
36. Pérez Pedrero E.J., García P.C. (2007) [ASRS v.1.1., a tool for attention-deficit/hyperactivity disorder screening in adults treated for addictive behaviors: psychometric properties and estimated prevalence] [in Spanish]. Adicciones, 19(4), 393-407.
37. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. (2007) The worldwide prevalence of ADHD: a systematic review and meta-regression analysis. The American Journal of Psychiatry, 164, 942-948.
38. Ramos-Quiroga J.A., Bosch R., Richarte V., Valero S., Gómez-Barrosa N., Nogueira M., Palomar G., Corralesa M., Sáez N., Corominas M., Real A., Vidal R., Chalita P., Casas M. (2012a) Validez de criterio y concurrente de la versión espãnola de la, 5(4), 229-235.
39. Ramos-Quiroga J.A., Diaz-Digon L., Comin M., Bosch R., Palomar G., Chalita P.J., Roncero C., Nogueira M., Torrens M., Casas M. (2012b) Criteria and concurrent validity of adult adhd section of the psychiatry research interview for substance and mental disorders. Journal of Attention Disorders, DOI: 10.1177/1087054712454191. [Epub ahead of print]
40. Ribasés M., Ramos-Quiroga J.A., Hervás A., Bosch R., Bielsa A., Gastaminza X., Bayés M. (2009) Exploration of 19 serotoninergic candidate genes in adults and children with attention deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Molecular Psychiatry, 14, 71-85, DOI: 10.1038/sj.mp.4002100.
41. Riggs P.D., Mikulich S.K., Whitmore E.A., Crowley T.J. (1999) Relationship of ADHD, depression, and non-tobacco substance use disorders to nicotine dependence in substance-dependent delinquents. Drug and Alcohol Dependence, 54, 195-205.
42. Rounsaville B.J., Anton S.F., Carroll K., Budde D., Prusoff B.A., Gawin F. (1991) Psychiatric diagnoses of treatment-seeking cocaine abusers. Archives of General Psychiatry, 48, 43-51.
43. Schubiner H., Tzelepis A., Milberger S., Lockhart N., Kruger M., Kelley B.J., Schoener E.P. (2000) Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. Journal of Clinical Psychiatry, 61, 244-251.
44. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(suppl. 20), 22-33.
45. Simon V., Czobor P., Balint S., Meszaros A., Bitter I. (2009) Prevalence and correlates of adult attention-deficity hyperactivity disorder: meta-analysis. The British Journal of Psychiatry, 194, 204-211.
46. Tang Y.L., Kranzler H.R., Gelernter J., Farrer L.A., Cubells J.F. (2007) Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects. American Journal on Addictions, 16, 343-351.
47. Van Emmerik-van Oortmerssen K., Van de Glind G., Van den Brink W., Smit F., Crunelle C.L., Swets M., Schoevers R.A. (2011) Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug and Alcohol Dependence, 122(1-2), 11-19.
48. Wilens T.E. (2004) Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatric Clinics of North America, 27, 283-301.
49. Wilens T.E., Martelon M., Joshi G., Bateman C., Fried R., Petty C., Biederman J. (2011). Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 50(6), 543-53.
50. Williams J.B., Gibbon M., First M.B., Spitzer R.L., Davies M., Borus J., Howes M.J., Kane J., Pope H.G., Jr, Rounsaville B. (1992) The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Archives of General Psychiatry, 49(8), 630-636.
51. Wood D., Wender P.H., Reimherr F.W. (1983) The prevalence of attention deficit disorder, residual type, or minimal brain dysfunction, in a population of male alcoholic patients. The American Journal of Psychiatry, 140, 95-98.
52. World Health Organization (WHO). (2012). Process of Translation and Adaptation of Instruments. http://www.who.int/substance_abuse/research_tools/translation/en/index.html. [24 April 2012].
53. Ziedonis D.M., Rayford, B.S., Bryant K.J., Rounsaville B.J. (1994). Psychiatric comorbidity in white and African-American cocaine addicts seeking substance abuse treatment. Hosp Commun Psychiatry, 45, 43-49.